HANSOH PHARMA (03692)
| Director | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|
| Chan Charles Sheung Wai | 31-May-19 | INED | |||
| Yang Dongtao | 31-May-19 | INED | |||
| Zhong Shengli | 16-Aug-18 | CoSec | |||
| Lyu Aifeng | 11-Mar-16 | ED | |||
| Sun Yuan | 02-Dec-15 | ED | |||
| Zhong Huijuan | 02-Dec-15 | Ch, CEO, Fdr | |||
| Wong Yuen Ki | 24-Jan-25 | 26-Dec-25 | CoSec | Resignation due to personal work arrangement. | |
| Wong Yuen Ki | 26-Dec-25 | J-CoSec, AuRep, Proc Agt | Resignation due to personal work arrangement. | ||
| Tam Sara Sze Wai | 29-Apr-24 | 24-Jan-25 | CoSec | ||
| Ms. Tam Sze Wai Sara | 24-Jan-25 | J-CoSec, AuRep, Proc Agt | Due to personal work arrangement. | ||
| Li Rita Yan Wing | 14-Jun-19 | 29-Apr-24 | CoSec | ||
| Li Yan Wing Rita | 29-Apr-24 | J-CoSec, AuRep, Proc Agt | No reasons provided | ||
| Ma Cuifang | 11-Mar-16 | 06-Sep-21 | Non-Executive Director | ||
| Lin Guoqiang | 31-May-19 | 01-Sep-20 | INED |